MENU

GMAB Genmab A/S ADS Forecast, Technical & Fundamental Analysis

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

GMAB is expected to report earnings to fall 46.09% to 30 cents per share on February 24

Genmab A/S ADS GMAB Stock Earnings Reports
Q4'26
Est.
$0.30
Q3'26
Beat
by $0.20
Q2'26
Beat
by $0.15
Q1'26
Missed
by $0.09
Q4'25
Beat
by $14.94
The last earnings report on November 05 showed earnings per share of 56 cents, beating the estimate of 36 cents. With 2.08M shares outstanding, the current market capitalization sits at 32.98B.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEGG1.150.12
+11.65%
Sports Entertainment Gaming Global Corporation
STHO7.780.08
+1.04%
Star Holdings
SHEN10.39-0.01
-0.10%
Shenandoah Telecommunications Co
HTO61.26-0.79
-1.27%
H2O America
TU8.66-0.12
-1.37%
Telus Corp

GMAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GMAB has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GMAB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMAB
1D Price
Change %
GMAB100%
-0.37%
AXON - GMAB
47%
Loosely correlated
+4.26%
PRME - GMAB
43%
Loosely correlated
+10.26%
BCYC - GMAB
42%
Loosely correlated
N/A
EDIT - GMAB
40%
Loosely correlated
-4.99%
RXRX - GMAB
40%
Loosely correlated
+1.13%
More
A.I. Advisor
published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2819
Web
https://www.genmab.com
Genmab A/S ADS (GMAB) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com